Since obesity has been suggested to induce SFRP5 expression in mice and humans [64], we hypothesize that NAFLD may result in the same effect by increasing metabolic imbalance. This evidence concerns the gene SFRP5 and metabolic dysfunction-associated steatotic liver disease.